Posts

Showing posts with the label Medical Device Testing Services Market Size

Medical Device Testing Services Market Size Poised To Reach USD 18.6 Billion By 2028

  San Francisco, 9 June 2021:   The Report  Medical Device Testing Services Market  Size, Share & Trends Analysis Report By Service (Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Test, Package Validation), By Phase, By Region, And Segment Forecasts, 2021 - 2028 The global medical device testing services market size is expected to reach USD 18.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2021 to 2028. Increasing complexity in product design and stringent government regulations are driving the market. A significant rise in preclinical spending is a recent trend among pharmaceutical and medical device companies, which is expected to significantly contribute to market growth. As per a survey carried out by the International Federation of Pharmaceutical Manufacturers and Associations in 2017, around USD 149.8 billion is spent on preclinical trials every year. With modern medical

Medical Device Testing Services Market Anticipated To Register A CAGR Of 11.5% For The Forecast Period From 2018 To 2025 : Grand View Research Inc.

San Francisco, 20 August 2019:   The Report   Medical Device Testing Services Market   Size, Share & Trends Analysis Report By Phase (Pre clinical, Clinical), By Service (Chemistry, Biocompatibility, Microbiology & Sterility Testing), By Region, And Segment Forecasts, 2018 – 2025 The global medical device testing services market size is expected to reach USD 13.4 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 11.5% during the forecast period. Increasing spending in preclinical phase of medical devices coupled with growing trend of outsourcing the services is expected to drive the market growth. Increasing demand for in-vitro tests is also expected to drive the market as many CROs are developing novel in-vitro methods to replace the traditional methods that require animal testing. Significant advancement in the development and standardization of such novel test methods, particularly for sensitization, c